|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBSCO_on1150849745 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
200408s2021 dcu ob 000 0 eng |
010 |
|
|
|a 2020016574
|
040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d OCLCO
|d OCLCQ
|d ORZ
|d OCLCF
|d EBLCP
|d YDX
|d OCLCO
|d N$T
|d CASUM
|d OCLCA
|d IBI
|d USU
|d OCLCO
|d K6U
|d VLB
|d OCLCQ
|
019 |
|
|
|a 1201226120
|a 1224122361
|
020 |
|
|
|a 9780890424742
|q electronic book
|
020 |
|
|
|a 0890424748
|q electronic book
|
020 |
|
|
|z 9780890424698
|q paperback
|q alkaline paper
|
020 |
|
|
|a 0890424691
|q (electronic bk.)
|
020 |
|
|
|a 9780890424698
|q (electronic bk.)
|
029 |
1 |
|
|a AU@
|b 000068792956
|
035 |
|
|
|a (OCoLC)1150849745
|z (OCoLC)1201226120
|z (OCoLC)1224122361
|
042 |
|
|
|a pcc
|
050 |
0 |
0 |
|a RC514
|b .A44 2021
|
060 |
1 |
0 |
|a WM 203
|
082 |
0 |
0 |
|a 616.89/8
|2 23
|
049 |
|
|
|a UAMI
|
110 |
2 |
|
|a American Psychiatric Association,
|e author,
|e issuing body.
|
245 |
1 |
4 |
|a The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia /
|c Guideline Writing Group, Systematic Review Group, Committee on Practice Guidelines, APA Assembly Liaisons.
|
250 |
|
|
|a Third edition.
|
264 |
|
1 |
|a Washington, DC :
|b American Psychiatric Association,
|c [2021]
|
300 |
|
|
|a 1 online resource (xi, 297 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Preceded by: Practice guideline for the treatment of patients with schizophrenia. 2nd ed. c2004.
|
504 |
|
|
|a Includes bibliographical references.
|
520 |
|
|
|a "The goal of this practice guideline is to improve the quality of care and treatment outcomes for patients with schizophrenia. The guideline aims to help clinicians optimize care for their patients by providing evidence-based statements that are intended to enhance knowledge and increase the appropriate use of evidence-based pharmacological and nonpharmacological treatments for schizophrenia. In addition, it includes statements related to assessment and treatment planning, which are an integral part of patient-centered care"--
|c Provided by publisher.
|
588 |
|
|
|a Description based on online resource; title from digital title page (viewed on November 16, 2020).
|
505 |
0 |
|
|a Introduction -- Rationale -- Scope of Document -- Overview of the Development Process -- Rating the Strengths of Guideline Statements and Supporting Research Evidence -- Proper Use of Guidelines -- Guideline Statement Summary -- Guideline Statements and Implementation -- Assessment and Determination of Treatment Plan -- Statement 1: Assessment of Possible Schizophrenia -- Implementation -- Balancing of Potential Benefits and Harms in Rating the Strength of the Guideline Statement
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Schizophrenia
|x Treatment.
|
650 |
1 |
2 |
|a Schizophrenia
|x therapy
|
650 |
|
6 |
|a Schizophrénie
|x Traitement.
|
650 |
|
7 |
|a Schizophrenia
|x Treatment
|2 fast
|0 (OCoLC)fst01106780
|
655 |
|
2 |
|a Practice Guideline
|
776 |
0 |
8 |
|i Print version:
|a American Psychiatric Association.
|t The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia
|b Third edition.
|d Washington, DC : American Psychiatric Association, [2020]
|z 9780890424698
|w (DLC) 2020016573
|w (OCoLC)1150804588
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2655308
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL6373791
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 301632608
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 2655308
|
994 |
|
|
|a 92
|b IZTAP
|